The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,181,083 in first-year total cost, median $201,127.
Most frequent study sections
- Arthritis and Musculoskeletal and Skin Diseases Clinical Trials Study Section [AMSC]6
Most frequent institutions
- CINCINNATI CHILDRENS HOSP MED CTR1
- DARTMOUTH COLLEGE1
- MEDICAL UNIVERSITY OF SOUTH CAROLINA1
- UNIV OF NORTH CAROLINA CHAPEL HILL1
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | Molecular biomarkers of improvement for patients with systemic sclerosis in an open label trial of mycophenolate mofetil1R21AR068035-01 | HINCHCLIFF, MONIQUE EVANGELINEWHITFIELD, MICHAEL L | DARTMOUTH COLLEGE, NH | $225,380 | AMSC |
| 2015 | Identification of Patellofemoral Pain Risk Factors Developed During Maturation1R21AR065068-01A1 | MYER, GREGORY DONALD | CINCINNATI CHILDRENS HOSP MED CTR, OH | $205,920 | AMSC |
| 2015 | Effect of Atorvastatin on Endothelial Function and Raynaud in Diffuse Scleroderma1R21AR066305-01A1 | DOMSIC, ROBYN THERESE | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $201,614 | AMSC |
| 2015 | Improving Disability in Knee Osteoarthritis by Targeting Neuromuscular Deficits1R21AR067560-01A1 | PIETROSIMONE, BRIAN | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $200,640 | AMSC |
| 2015 | Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma1R21AR065089-01A1 | SILVER, RICHARD M. | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $175,137 | AMSC |
| 2015 | Topical Antibiotic Treatment for Spine Surgical Site Infections1R21AR068632-01 | FLUM, DAVID R | UNIVERSITY OF WASHINGTON, WA | $172,392 | AMSC |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.